All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MV-01LX143 | Anti-MAGE1 (M3H67) h(CD28-CD3ζ) CAR, pMMLV | Human | M3H67 | human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX144 | Anti-MAGE1 (M/YC-15) h(CD28-CD3ζ) CAR, pMMLV | Human | M/YC-15 | human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX145 | Anti-MAGE1 (Hyb3) h(CD28-CD3ζ) CAR, pMMLV | Human | Hyb3 | Human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX388 | Anti-MAGE1 (M3H67) h(41BB-CD3ζ) CAR, pMMLV | Human | M3H67 | human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX389 | Anti-MAGE1 (M/YC-15) h(41BB-CD3ζ) CAR, pMMLV | Human | M/YC-15 | human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX390 | Anti-MAGE1 (Hyb3) h(41BB-CD3ζ) CAR, pMMLV | Human | Hyb3 | Human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-SB-02LX140 | Anti-MAGE1 (M3H67) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | M3H67 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX141 | Anti-MAGE1 (M/YC-15) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | M/YC-15 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX142 | Anti-MAGE1 (Hyb3) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | Hyb3 | Human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX382 | Anti-MAGE1 (M3H67) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 | Human | M3H67 | Human | scFv-CD28-OX40-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX383 | Anti-MAGE1 (M/YC-15) h(CD28-OX40-CD3ζ) CAR, pSBCAR1 | Human | M/YC-15 | Human | scFv-CD28-OX40-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0323-LX3938 | TRAC-MAGE1 (X3XT140) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT140 | Human | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3939 | TRAC-MAGE1 (X3XT141) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT141 | Human | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3940 | TRAC-MAGE1 (X3XT142) h(CD28-41BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT142 | Human | Homology arm-EF1a-scFv-CD28-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4180 | TRAC-MAGE1 (X3XT140) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT140 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4181 | TRAC-MAGE1 (X3XT141) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT141 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4182 | TRAC-MAGE1 (X3XT142) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT142 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4422 | TRAC-MAGE1 (X3XT140) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT140 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4423 | TRAC-MAGE1 (X3XT141) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT141 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX4424 | TRAC-MAGE1 (X3XT142) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | X3XT142 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0823-LX76 | Anti-hMAGE1 (B3) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | B3 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION